JP2024537394A5 - - Google Patents
Info
- Publication number
- JP2024537394A5 JP2024537394A5 JP2024522487A JP2024522487A JP2024537394A5 JP 2024537394 A5 JP2024537394 A5 JP 2024537394A5 JP 2024522487 A JP2024522487 A JP 2024522487A JP 2024522487 A JP2024522487 A JP 2024522487A JP 2024537394 A5 JP2024537394 A5 JP 2024537394A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- diazepine
- thieno
- triazolo
- cpd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/123848 | 2021-10-14 | ||
| CN2021123848 | 2021-10-14 | ||
| CNPCT/CN2021/133363 | 2021-11-26 | ||
| CN2021133363 | 2021-11-26 | ||
| PCT/CN2022/125080 WO2023061440A1 (en) | 2021-10-14 | 2022-10-13 | Modified proteins and protein degraders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537394A JP2024537394A (ja) | 2024-10-10 |
| JP2024537394A5 true JP2024537394A5 (https=) | 2025-10-21 |
Family
ID=85987275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522487A Pending JP2024537394A (ja) | 2021-10-14 | 2022-10-13 | 修飾タンパク質およびタンパク質分解剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250235543A1 (https=) |
| EP (1) | EP4416145A1 (https=) |
| JP (1) | JP2024537394A (https=) |
| CN (1) | CN118451078A (https=) |
| AU (1) | AU2022362494A1 (https=) |
| CA (1) | CA3234615A1 (https=) |
| IL (1) | IL312013A (https=) |
| MX (1) | MX2024004525A (https=) |
| WO (1) | WO2023061440A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240020735A (ko) | 2021-05-07 | 2024-02-15 | 카이메라 쎄라퓨틱스 인코포레이티드 | Cdk2 분해제 및 그 용도 |
| US20260092062A1 (en) * | 2022-09-26 | 2026-04-02 | Rectify Pharmaceuticals, Inc. | Pyridine carboxamide compounds and their use in treating medical conditions |
| CN121005703A (zh) * | 2024-05-24 | 2025-11-25 | 中国科学院广州生物医药与健康研究院 | 一种酰胺吲嗪类化合物及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3445765A4 (en) * | 2016-04-22 | 2019-09-18 | Dana Farber Cancer Institute, Inc. | DECREASE OF CYCLINE-DEPENDENT KINASE 4/6 (CDK4 / 6) BY CONJUGATION OF CDK4 / 6 INHIBITORS WITH E3-LIGASE LIGANDS AND METHODS OF USE |
| EP3807272A1 (en) * | 2018-06-13 | 2021-04-21 | Amphista Therapeutics Ltd | Bifunctional molecules for targeting rpn11 |
| US20220002291A1 (en) * | 2018-11-02 | 2022-01-06 | The Wistar Institute Of Anatomy And Biology | Proteolysis-targeting chimeras |
| WO2020173440A1 (en) * | 2019-02-27 | 2020-09-03 | Cullgen (Shanghai), Inc. | Cyclic-amp response element binding protein (cbp) and/or adenoviral e1a binding protein of 300 kda (p300) degradation compounds and methods of use |
| WO2020206608A1 (en) * | 2019-04-09 | 2020-10-15 | Ranok Therapeutics (Hangzhou) Co., Ltd. | Methods and compositions for targeted protein degradation |
| WO2020219650A1 (en) * | 2019-04-23 | 2020-10-29 | Dana-Farber Cancer Institute, Inc. | Degraders of cyclin-dependent kinase 12 (cdk12) and uses thereof |
| CN112409376A (zh) * | 2019-08-20 | 2021-02-26 | 华东师范大学 | 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用 |
| CN120623106A (zh) * | 2019-09-30 | 2025-09-12 | 协和麒麟株式会社 | Bet降解剂 |
| WO2021239117A1 (en) * | 2020-05-28 | 2021-12-02 | Cullgen (Shanghai) , Inc. | Modified proteins and protein degraders |
-
2022
- 2022-10-13 IL IL312013A patent/IL312013A/en unknown
- 2022-10-13 WO PCT/CN2022/125080 patent/WO2023061440A1/en not_active Ceased
- 2022-10-13 CN CN202280082680.9A patent/CN118451078A/zh active Pending
- 2022-10-13 JP JP2024522487A patent/JP2024537394A/ja active Pending
- 2022-10-13 US US18/700,898 patent/US20250235543A1/en active Pending
- 2022-10-13 MX MX2024004525A patent/MX2024004525A/es unknown
- 2022-10-13 CA CA3234615A patent/CA3234615A1/en active Pending
- 2022-10-13 AU AU2022362494A patent/AU2022362494A1/en active Pending
- 2022-10-13 EP EP22880376.3A patent/EP4416145A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024537394A5 (https=) | ||
| RU2472797C2 (ru) | ПРОИЗВОДНЫЕ 2-[(2-(ФЕНИЛАМИНО)-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА | |
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2013510122A5 (https=) | ||
| JP2015511629A5 (https=) | ||
| RU2001114978A (ru) | N-ариламиды антраниловой кислоты и тиоантраниловой кислоты | |
| JP2016506387A5 (https=) | ||
| RU2003114740A (ru) | Азотсодержащие ароматические производные | |
| RU2008100606A (ru) | Ингибиторы сфингозинкиназы | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| RU2006146632A (ru) | Производные хиназолинона, полезные в качестве ванилоидных антагонистов | |
| RU2011152891A (ru) | Диарилгидантоины | |
| RU2007132161A (ru) | Замещенные ариламины и их применение в качестве модуляторов 5-ht6-рецептора | |
| JP2008535871A5 (https=) | ||
| RU2004130488A (ru) | Пиримидиновые производные | |
| CA2660529A1 (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| RU2007148217A (ru) | Получение производных n-фенил-2-пиримидинамина | |
| JP2011509309A5 (https=) | ||
| CA2436980A1 (en) | Amido ether substituted imidazoquinolines | |
| CA2392570A1 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines | |
| JP2014502979A5 (https=) | ||
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| RU2007121219A (ru) | Диазациклоалканы как агонисты окситоцина | |
| RU2011130566A (ru) | Сочетание ингибиторов аврора киназы и анти-cd 20 антител |